What is Insulet's revenue?

Insulet (PODD) generated $2.9B in revenue over the trailing twelve months, up 31.9% year over year.

Is Insulet profitable?

Insulet reported $302.8M in net income over the trailing twelve months, a 10.4% net margin.

What are Insulet's profit margins?

Gross margin is 71.0% and operating margin is 17.5%, with a 10.4% net margin.

What is Insulet's earnings per share?

Insulet's diluted EPS over the trailing twelve months is $4.29.

Where does Insulet's income statement data come from?

Every line is extracted from Insulet's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Insulet PODD Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$2.9B+31.9%	$2.71B+30.7%	$2.52B+27.1%	$2.36B+26.0%	$2.2B+23.5%
Total cost of revenue	$841M+29.2%	$768.2M+22.7%	$719.6M+18.4%	$690.2M+18.9%	$650.9M+17.4%
Gross profit	$2.06B+33.1%	$1.94B+34.2%	$1.8B+31.0%	$1.67B+29.2%	$1.55B+26.2%
Gross margin	71%+0.6pp	71.6%+1.8pp	71.5%+2.1pp	70.7%+1.7pp	70.4%+1.5pp
Research and development	$331.2M+44.6%	$301.1M+37.1%	$270.8M+34.7%	$248.5M+21.9%	$229M+11.7%
Selling, general and administrative	$1.22B+24.9%	$1.17B+27.0%	$1.09B+25.9%	$1.01B+24.3%	$978.2M+26.7%
Operating income	$507.2M+48.9%	$473.9M+53.5%	$436.9M+42.8%	$407.3M+49.4%	$340.7M+36.7%
Operating margin	17.5%+2.0pp	17.5%+2.6pp	17.3%+1.9pp	17.3%+2.7pp	15.5%+1.5pp
Interest expense	$64.8M+57.3%	$59.3M+38.9%	$53M+29.9%	$49.8M+28.4%	$41.2M+9.9%
Other income (expense), net	$17.2M+332%	$14.3M+342%	$11.2M+380%	-$4.3M-4,400%	-$7.4M-535%
Income before income taxes	$404.4M+37.7%	$339.6M+13.1%	$310.8M+4.7%	$270.9M+1.2%	$293.6M+19.8%
Income tax expense	$101.5M+185%	$92.3M+172%	$53.8M+143%	$24M+119%	-$119.4M-1,195%
Net income	$302.8M-24.7%	$247.1M-40.9%	$246.2M-41.5%	$236.1M-40.3%	$402.2M+71.9%
Net margin	10.4%-7.9pp	9.1%-11.1pp	9.8%-11.5pp	10%-11.1pp	18.3%+5.2pp
Diluted earnings per share	$4.29-22.7%	$3.49-39.6%	$3.44-41.4%	$3.28-40.7%	$5.55+66.7%
EBITDA	$602.1M+41.9%	$564.3M+44.8%	$524.4M+36.5%	$494.1M+41.9%	$424.4M+31.1%
EBITDA margin	20.8%+1.5pp	20.8%+2.0pp	20.8%+1.4pp	20.9%+2.3pp	19.3%+1.1pp
EBIT	$507.2M+48.9%	$473.9M+53.5%	$436.9M+42.8%	$407.3M+49.4%	$340.7M+36.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Insulet.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Insulet's revenue?: Insulet (PODD) generated $2.9B in revenue over the trailing twelve months, up 31.9% year over year.
Is Insulet profitable?: Insulet reported $302.8M in net income over the trailing twelve months, a 10.4% net margin.
What are Insulet's profit margins?: Gross margin is 71.0% and operating margin is 17.5%, with a 10.4% net margin.
What is Insulet's earnings per share?: Insulet's diluted EPS over the trailing twelve months is $4.29.
Where does Insulet's income statement data come from?: Every line is extracted from Insulet's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.